Figure 1 (Prasugrel Tablets 1)
Prasugrel Tablet, Film Coated
Product Images NDC 65162-002
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Prasugrel (NDC 65162-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (Prasugrel Tablets 2)
10 (Prasugrel Tablets 3)
10 (Prasugrel Tablets 4)
This appears to be a chart or graph that displays the percentage of cardiovascular deaths, non-fatal strokes, and non-fatal events over a period of days starting from randomization. However, without more context, it is difficult to provide a detailed description of the data.*
10 (Prasugrel Tablets 5)
10 (Prasugrel Tablets 6)
This appears to be a table showing baseline characteristics of a study population, including information such as body weight, region, diabetes, and previous medical history. It also includes data on stent type and medication use. The last part of the text seems to show percent event rates and hazard ratios for different medications. Overall, this appears to be a research study or clinical trial.*
10 (Prasugrel Tablets 7)
This text appears to be a table showing baseline characteristics for a medical study or research. It includes demographic information such as age, gender, body weight, and region, as well as medical history like diabetes mellitus, metabolic syndrome, previous MI/PCI/CABG, and previous TIA/stroke. There is also information on the stent type and GP libla inhibitor use. The table concludes with percentages and a hazard ratio, with a recommendation that Prasugrel is better than Clopidogrel.*
Vb (Prasugrel Tablets 8)
NDC 65162-001-03 is a medicine containing 5 mg of prasugrel hydrochloride, USP. It is in the form of film-coated tablets and should be kept out of the reach of children. It is suggested to store this medication at 20° to 25°C (68° to 77°F) with the container closed and without removing the desiccant from the bottle. This is a prescription drug, so please use it with a doctor's recommendation. This medication is supplied by Amneal Pharmaceuticals LLC, Bridgewater, NJ.*
Ad (Prasugrel Tablets 9)
Each film-coated tablet of Prasugrel contains 10 mg of prasugrel hydrochloride, equivalent to USP. The typical dosage of Prasugrel tablets can be found in the prescribing information. It is advised to keep this medication out of children's reach and in its original container at a temperature of 20° to 25°C (68° to 77°F). Do not remove the container unless necessary. The product is manufactured by Amneal Pharmaceuticals Pvt Ltd in Ahmedabad, INDIA, and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. However, the text does not provide any indication or suggestion regarding the use and benefits of Prasugrel tablets.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
